Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of Lebrikizumab in Uncontrolled Asthma on ICS and a Second Controller
jRCT2080222268Phase 3
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Oct 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lebrikizumab in asthma (3 arms), sponsored by Chugai Pharmaceutical Co., Ltd.
02
Drugs
lebrikizumab
03
Conditions
asthma
Beyond the preview
Go deeper on jRCT2080222268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222268.